Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
57 /100
HIGH RISK
Score updated Oct 13, 2026

COEP — Coeptis Therapeutics Holdings Inc Dilution Risk Tracker

Track COEP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track COEP — Get alerts when the score changes →

As of October 13, 2026, Coeptis Therapeutics Holdings Inc (COEP) has a DilutionWatch DilutionScore of 57/100, rated HIGH dilution risk. Coeptis Therapeutics Holdings Inc has a market capitalization of $102.06M, 53.00M shares outstanding. Stored dilution-related fields include ATM program capacity of $20.00M, 543.6K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
10
📊 Float Risk
100
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $20M remaining capacity
🔔 Track COEP — Get forecast alerts →

Market Data

Market Cap$102.06M
Shares Outstanding53.00M
Float5.25M
Cash$15.54M
Debt$150.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore57/100DilutionWatch score record
Shares Outstanding53.00MVerified float table or market cache
Public Float5.25MVerified float table or market cache
Market Cap$102.06MMarket data cache
Cash Runway24.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$20.00MSEC-derived dilution fields
Outstanding Warrants543.6KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

Institutional data not yet available.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2026-08-13
8-K 8K EVENT 2026-05-01
4 INSIDER TRANSACTION 2026-04-30
4 INSIDER TRANSACTION 2026-04-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual COEP Dilution Snapshot

Coeptis Therapeutics Holdings Inc (COEP) has a DilutionScore of 57/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

COEP's DilutionScore is currently 57/100 (High risk), with 2 score changes tracked over 89 days. The score deteriorated from 61/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202657/100HIGH16 days
Aug 22 – Sep 27, 202661/100HIGH37 days
Jul 16 – Aug 21, 202684/100CRITICAL36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

COEP shares outstanding have increased 8.0% from 5.76M (Mar 2026) to 6.22M (Mar 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Mar 25, 20266.22M5.25M▲ 1.80%
Mar 23, 20265.76M5.16M▲ 16.54%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track COEP Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment COEP files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking COEP — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for COEP
COEP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.